LunaRich positions Reliv as the nutritional epigenetics company, and we believe will help produce continued growth in the months and years to come.
CHESTERFIELD, MO (PRWEB) November 27, 2013
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today attributed much of the company’s recent sales growth to Reliv bringing the science of nutritional epigenetics to the marketplace. “In the past year we’ve positioned ourselves as the industry leader in this emerging field,” said Ryan Montgomery, Reliv president. “LunaRich® is the first epigenetic superfood, and it’s giving our consumers a whole new way to think about nutrition and human health.”
Reliv’s LunaRich soy powder and LunaRich X™ optimize bioactive lunasin like no other products available today. Lunasin, a naturally occurring soy peptide, is the first nutritional compound identified to promote optimal cellular health through an epigenetic mechanism of action. In July 2013 Reliv entered into an exclusive license for the intellectual property of Soy Labs LLC related to lunasin, including ingredient patents and proprietary manufacturing technologies. View the press release.
“For the first time we control an ingredient in its entirety, from the extraction process to the patented mechanisms of action within the body,” said Montgomery. “And this exclusivity has resonated among consumers and distributors alike. More people are interested in not only taking the products, but also starting their own Reliv businesses.”
In the third quarter of 2013, Reliv’s net U.S. sales totaled $13.2 million, an increase of $1.1 million, or 9.0 percent, compared to third-quarter 2012 net sales. Those sales were led by the flagship products in the LunaRich line, Reliv Now® and LunaRich X, which made up 18.1 and 13.2 percent of U.S. sales, respectively. The number of new Master Affiliates, the level at which distributors are eligible to earn generation royalties, increased to 694 during the third quarter of 2013 compared to 284 during same period in 2012, an increase of 144%. View Reliv’s third quarter 2013 earnings release.
“LunaRich and the epigenetic science behind it are changing the way Reliv consumers think about nutrition,” said Montgomery. “People today want to take control of their health, and nutritional epigenetics offers a breakthrough new way to do exactly that. LunaRich positions Reliv as the nutritional epigenetics company, and we believe this will help produce continued growth in the months and years to come.”
About Reliv International, Inc.
Reliv International, based in Chesterfield, Mo., produces nutritional supplements that promote optimal nutrition along with premium skincare products. Reliv supplements address essential nutrition, weight loss, athletic performance, digestive health, women's health, anti-aging and healthy energy. Reliv is the exclusive provider of LunaRich® products, which optimize levels of lunasin, the peptide behind many of soy’s health benefits. The company sells its products through an international network marketing system of independent distributors in 16 countries. Learn more about Reliv at reliv.com, or on Facebook, Twitter or YouTube.